Objectives. This study was undertaken to determine which exercise and radionuclide ventriculographic variables predict prognosis in advanced heart failure.
proportional hazards survival model, right ventricular ejectioa fraction >0.35 at exercise (p < 0.01) and %Vo 2 >45% (p = 0.01) were selected as independent predictors of overall survival. Univariate predictors of event-free survival included right ventricular ejection fraction >0. 35 at rest (p = 0.01) and >0. 35 at exercise (p < 0.01), functional class II (p < 0.05) and %Vo 2 ->45% (p = 0.05). Right ventricular ejection fraction >0. 35 at exercise (p ----0.01) was the only independent predictor of event-free survival ia a multivariate proportional hazards model. Cardiac index at resl:, Voz, left ventricular ejection fraction at rest, and exercise-relatot increase or decrease >0.05 in left or right ventricnlar ejection fraction were not predictive of overall or event-free survival in any univariate or multivariate analysis.
Conclusions. 1) Right ventricular ejection fraction >0.35 at rest and exercise is a more potent predictor of survival in advanced heart failure than Vo 2 or %Vo2; 2) %Voz rather than Vo 2 predicts survival in advanced heart failure; 3) neither %Vo 2 nor Vo 2 predicts survival to the combined end point of death or admissioa for inotropic or mechanical support in patients with advanced heart failure.
(J Am CoU Cardiol 1995; 25:1143-53) Despite recent advances in medical and surgical therapy, patients with symptomatic congestive heart failure still have a generally poor prognosis (1) . A variety of clinical, hemodynamic and ventriculographic variables, including age, presence of a third heart sound ($3) ventricular gallop, left ventricular ejection fraction, left ventricular end-diastolic volume index, pulmonary capillary wedge pressure and pulmonary vascular resistance, have been shown to predict prognosis in large groups of patients with heart failure with symptoms of varying severity (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) . Markers of reflex neurohumoral activation, such as plasma norepinephrine, plasma renin activity and atrial naturietic peptide, are elevated in heart failure and have also been shown to portend a poorer prognosis in similar groups (17) (18) (19) (20) . However, considerable difficulty remains in estimating the prognosis of a subgroup of patients at greatest risk--those with advanced heart failure referred for evaluation for cardiac transplantation (21) . In this more homogeneous patient group, conventional clinical, hemodynamic and neurohumoral predictors of prognosis have not been shown to be as useful in predicting outcome. Functional capacity assessed by peak oxygen consumption (peak Vo2) during cardiopulmonary exercise testing has been shown to predict survival in advanced heart failure (21-231,. Peak Vo 2 <10 ml/kg per min is associated with the poorest prognosis, and such patients are often recommended for cardiac transplantation (21) . Peak Vo 2 >14 ml/kg per rain predicts overall 2-year survival at least equivalent to that for cardiac transplantation, and such patients are usually followed on medical therapy. Patients with peak Vo 2 between 10 and 14 ml/kg per min have an intermediate prognosis.
Despite the utility of peak Vo: in risk stratification ~f patients with advanced heart failure, little is known about additional prognostic features that can be identified during cardiopulmonary exercise testing. This study attempted to determine whether rest and peak exercise first-pass radionuclide ventriculography performed during simultaneous cardiopulmonary exercise testing might provide any additional prognostic information beyond that obtained by measurement of peak Vo2.
Methods
Study patients. The study group included 67 ambulatory patients with advanced, symptomatic heart failure referred for evaluation for cardiac transplantation between 1988 and 1992 to the Massachusetts General Hospital Heart Failure Center. All patients underwent simultaneous cardiopulmonary exercise testing and rest and peak exercise first-pass radionuclide ventriculography as part of initial evaluation for cardiac transplantation. Patients unable to exercise because of a requirement for intravenous inotropic agents or mechanical circulatory support were excluded. Mean (_+SD) patient age was 51 _+ 10 years (range 17 to 61), and 79% were male. Heart failure etiology was ischemic (46%) or dilated (54%) cardiomyopathy; 24% of patients were in New York Heart Association functional class II, 58% in class III, and 18% in class IV. Before cardiopulmonary exercise testing, medical therapy with digoxin, diuretic drugs and angiotensin-converting enzyme inhibitors had been optimized on the basis of symptoms, physical examination, renal function and, in most instances, invasive hemodynamic monitoring. Therapy was adjusted to achieve a pulmonary capillary wedge pressure <18 mm Hg and cardiac index >2.2 liters/rain per m a whenever possible.
Exercise testing and radionuclide ventriculography. Exercise testing was performed after an overnight fast; oral medications were not withheld. Upright symptom-limited cycle ergometry was performed on an electronically braked bicycle ergometer (pedal-mode ergometer, Warren E. Collins, Inc.) at a constant cycle speed of 60 rpm using a continuous ramp protocol in which work load increased continuously by 12.5 W/min up to peak tolerance. Heart rate, blood pressure and the 12-lead electrocardiogram were monitored continuously. Predicted maximal heart rate was estimated as 220 beats/rain minus age. Peak work load (W) and exercise duration (rain) were noted. Breath-to-breath respiratory gas exhange analysis was performed by means of a mouthpiece and nose clips and a metabolic cart (2001 System, Medical Graphics Corp.).
Rest ventilatory and gas exchange data were averaged over the last 2 rain of the rest period. During exercise, data were averaged over contiguous 30-s intervals, except at peak exercise, when 15-s averaging was used to improve time resolution. Oxygen uptake, carbon dioxide output, respiratory quotient, minute ventilation and ventilatory equivalent for oxygen were calculated by on-line computer as previously reported (24) . The anaerobic threshold was determined by the V slope method (25) . Maximal oxygen uptake (peak Vo2) was defined as the highest Vo 2 measured during the last minute of symptom-limited exercise. Predicted values for maximal oxygen consumption during upright bicycle exercise were calculated from a gender-specific regression equation incorporating age, height and weight (26) .
Rest and peak exercise first-pass radionuclide ventriculography were performed with a multicrystal gamma camera (Baird-Atomic System 77, Baird Corporation) in the anterior view with the patient upright at rest and at peak exercise. Red blood cells were pretreated with 3 ml of intravenous stannous pyrophosphate 20 min before first-pass radionuclide ventriculographic imaging. Images were acquired at 0.025 s/frame after the intravenous bolus administration of 10 mCi of technetium99m (Tc-99m) pertechnetate at rest and after a second intravenous bolus of 15 mCi Tc-99m pertechnetate at peak exercise. Each study was completed within 50 s.
Data were stored and analyzed with the use of MAC77 software (Scinicor Inc.). A region of interest was selected over each ventricle, and a time-activity curve was generated. Peak activity was considered to be end-diastole, and the activity minimum was considered to be end-systole. Only cycles with >70% of the maximal end-diastolic activity in the end-diastolic frame were included for analysis. Background was taken as the activity within the ventricular region of interest before the first ventricular beat. The background-subtracted ventricular beats were summated to generate a single representative cardiac cycle. The right and left ventricular ejection fractions were derived from time-activity curves as (End-diastolic countsEnd-systolic counts)fEnd-diastolic counts. Previous studies from our laboratory (27) have demonstrated an ejection fraction estimation interobserver error of _+4% for this method of ejection fraction calculation. The left ventricular end-diastolic and end-systolic volumes were calculated from the regions of interest with the use of a single-plane area-length method and divided by the body surface area to obtain the left ventricular end-diastolic and end-systolic volume indexes. Left ventricular stroke volume index was calculated as end-diastolic volume index minus end-systolic volume index.
Preserved right ventricular ejection fraction at rest was defined as right ventricular ejection fraction ->0.35, the lower limit for right ventricular ejection fraction within 2 SD of the mean right ventricular ejection fraction measured in our laboratory in 16 healthy sedentary volunteer control subjects. In accord with previous published studies ( [28] [29] [30] [31] , an increase in rest left or right ventricular ejection fraction ->0.05 at peak exercise was considered normal.
Clinical follow-up and outcome. Medical therapy was optimized before hospital discharge. After initial evaluation for transplantation, patients were followed up every 3 to 6 months at the Massachusetts General Hospital Heart Failure Center. Outpatient medical therapy was adjusted as necessary to achieve an edema-free state and maximally tolerated dose of vasodilator therapy.
Follow-up data were collected by review of all Massachusetts General Hospital and clinic records and telephone interview of the referring physician, patient or patient's family. Follow-up data collected included date of death, date of transplantation, need for admission to hospital for inotropic or Deaths occurring within 24 h without antecedent symptomatic progression of heart failure were defined as sudden. Deaths from progressive symptoms of hemodynamic deterioration were defined as due to progressive heart failure. Two study end points were defined: 1) death (either sudden or from progressive heart failure) and 2) a combined end point of either death or pretransplantation admission for inotropic or mechanical bridging to cardiac transplantation.
Statistical analysis. Univariate and multivariate analyses were performed to determine which demographic, exercisederived and radionuclide ventriculographic variables were predictive of the two study end points, 1) death, and 2) the combined end point. Univariate and multivariate analyses for each end point were performed separately. Univariate and multivariate analyses of survival to each end point were also performed separately. Overall survival was defined as freedom from death (sudden or due to progressive heart failure); event-free survival was defined as freedom from the combined end point (death or intotropic/mechanical bridging to transplantation).
To allow clinically meaningful univariate and multivariate comparisons between groups, the following continuous variables were analyzed as stratified ordinal variables: peak Voz (-<10, >10 to <14 and ->14 ml/kg per min); peak percent predicted age-and sex-adjusted Vo 2 (-<30, >30 to <45 and ->45 ml/kg per min); right ventricular ejection fraction at rest or exercise (<0.35 or ->0.35); left ventricular ejection fraction at rest (-<0.20, >0.20 to <0.30, and ->0.30); left ventricular end-diastolic volume index at rest (<150 or ->150 ml/m2); left ventricular end-systolic volume index at rest (<120 or ->120 ml/m2); and cardiac index at rest (<2.8 or ->2.8 liters/ m2). A right ventricular ejection fraction at rest or exercise >-0.35 was considered preserved right ventricular ejection fraction in accord with studies at our and other institutions (27) . Right and left ventricular ejection fraction discordance ("ventricular discordance") was defined as right ventricular ejection fraction at rest minus left ventricular ejection fraction at rest ->0.10. Peak Vo2 and peak %Vo 2 were stratified into three groups in accord with previous studies (22) and to allow maximal opportunity to detect significant univariate and multivariate associations with other variables. Left ventricular end-diastolic volume index, left ventricular end-systolic volume index and cardiac index were stratified by the mean values for the study group. All analyses were performed using these stratified variables, which were recorded for all 67 patients. Because of radionuclide first-pass bolus dispersion, seven patients did not have accurate determination of left ventricular ejection fraction at peak exercise or left ventricular enddiastolic volume index at peak exercise; these variables were therefore not included in any univariate or multivariate anaLyses.
Univariate differences between groups were compared by Fisher exact tests for dichotomous variables, Mantel-Haenszel chi-square tests for trend for nondichotomous ordinal variables, nonpaired t tests for normally distributed continuous variables and Wilcoxon rank-sum tests for nonnormally distributed continuous variables. Multivariate logistic regression was used to identify the most important predictors of death and the combined end point. Multiple linear best possible all-subsets regression was used to identify the predictors of peak %Vo 2. Life-table analysis was used to determine overall and event-free survival for the entire study group, Differences in overall and event-free survival between groups were detected by the Kaplan-Meier product-limit method and compared by the Peto-Prentice generalized log-rank test for two groups or the Peto-Prentice generalized log-rank test for trend for more than two groups. To identify the most important predictors of overall and event-free survival, multivariate Cox proportional hazards analysis was used. In analyses of overall survival, cardiac transplantation was considered a censored observation; in analyses of event-free survival, hospital admission for inotropic or mechanical bridging to transplantation was considered a noncensored observation, and elective admission for transplantation without inotropic/mechanical bridging was considered a censored observation.
A p value <0.05 was considered statistically significant. All analyses were performed by BMDP statistical software.
Results
Clinical characteristics, cardiopuimonary exercise testing results and radionuclide ventriculographic findings. The clinical characteristics and results of cardiopulmonary exercise testing and first-pass radionuclide ventriculography are presented in Table 1 . Medical therapy included digoxin (79%), diuretic drugs (83%), angiotensin-converting enzyme inhibitots (77%), hydralazine (8%) and vesnarinone (5%); 29% of patients were receiving type 1A or type 3 antiarrhythmic agents. An automatic implantable cardioverter-defibrillator had previously been implanted in 17% of patients.
There were no significant adverse outcomes during cardiopulmonary exercise testing; three patients experienced transient angina. At peak exercise, mean systolic blood pressure was 120 _+ 24 mm Hg, mean peak heart rate was 134 _+ 37 beats/min, and mean age-adjusted peak heart rate achieved 82 +_ 22% (Table 1) . Mean peak Vo 2 was 11.8 _+ 4.2 ml/kg per min (range 6.2 to 28.7). Division into strata revealed that 24 patients (36%) had a peak Vo 2 <10 ml/kg per min, 26 (39%) had a peak Vo 2 between 10 and 14 ml/kg per rain, and 17 (25%) had a peak Vo2 >14 ml/kg per min. Mean peak %Vo2 was 38 _+ 12%. Further division into strata revealed that 15 patients (22%) had peak %Vo 2 <30%, 32 (48%) had peak %Vo 2 between 30% and 45%, and 20 (30%) had peak %Vo2 >45%. Mean respiratory gas-exchange ratio at peak exercise was 1.13 _+ 0.19; mean anaerobic threshold was 7.9 +_ 2.3 ml/kg per min; and mean anaerobic threshold as a percent of peak Vo z was 66.7 _+ 11%.
Mean left ventricular ejection fraction at rest was 0.22 _+ Data presented are mean value _+ SD (range) or percent of patients. AT = anaerobic threshold; AT %Vo 2 = anaerobic threshold as a percent of measured peak Vo2; CI = cardiac index; CM = cardiomyopathy; ex -exercise; HRheart rate; LVEDVI = left ventricular end-diastolic volume index; LVEF -left ventricular ejection fraction; LVESVI -left ventricular end-systolic volume index; MPHR = maximal predicted heart rate; NYHA = New York Heart Association functional class; R = respiratory exchange ratio; RVEF = right ventricular ejection fraction; SBP = systolic blood pressure; Voz = peak oxygen consumption; %Vo 2 -peak percent predicted oxygen consumption.
0.07 (range 0.09 to 0.39) and did not increase significantly during exercise (left ventricular ejection fraction at peak exercise 0.24 _+ 0.07, p = NS). At peak exercise left ventricular ejection fraction increased ->0.05 in 11 patients (17%) and decreased ->0.05 in 4 (6%). Mean right ventricular ejection fraction at rest was also depressed at 0.29 _+ 0.11 (range 0.10 to 0.53) and did not increase significantly with exercise (right ventricular ejection fraction at peak exercise 0.28 _+ 0.11, p = NS). At peak exercise, right ventricular ejection fraction increased >0.05 in 12 patients (18%) and decreased ->0.05 in 11 (17%). A total of 24 patients (36%) had a right ventricular ejection fraction at rest ->0. 35 duration of heart failure symptoms or diagnosis (ischemic vs. dilated cardiomyopathy) between those patients with and without ventricular discordance. Mean left ventricular endsystolic volume index was 121 _+ 47 ml/m 2 at rest. Outcome and survival. Sixty patients (90%) were deemed suitable candidates and were eventually listed for cardiac transplantation. Median duration of follow-up was 58 weeks (range 1 to 180). Seventeen patients (23%) were admitted to the hospital for exacerbation of heart failure (excluding admissions for inotropic/mechanical support as bridging to transplantation); 30 patients (45%) required an increased dose of an established or a new diuretic drug; and 13 patients (20%) required an increased dose of angiotensin-converting enzyme inhibitor during follow-up. Only 1 of the 17 patients with an automatic implantable cardioverter-defibrillator experienced an automatic implantable cardioverter-defibrillator firing during follow-up.
Sixteen patients (24%) died, of whom 14 (88%) died out of hospital and suddenly. Two nonsudden deaths occurred in hospitalized patients awaiting transplantation (progressive heart failure [n = 1]; intractable heart failure during an episode of catheter-related sepsis [n = 1]).
A total of 29 patients (42%) reached the combined end point of death (n = 16) or hospital admission for inotropic/ mechanical bridging to transplantation (n = 13). Among the 23 patients (35% of the study group) who underwent transplantation, 13 (56% of all who underwent transplantation) were admitted for inotropic/mechanical bridging before transplantation; 10 patients (44% of all who underwent transplantation) underwent transplantation as outpatients.
By life-table analysis, median overall survival was estimated to be 140 weeks and median event-free survival 98 weeks (Fig. 1) . Tables 1 and 2 .
Predictors of death and combined end point. From among the clinical, exercise and radionuclide variables recorded during cardiopulmonary exercise testing (age, gender, diagnosis, functional class, percent predicted heart rate maximum achieved, peak Vo 2, peak %Vo2, watts achieved, right ventricular ejection fraction at rest and at exercise, left ventricular ejection fraction at exercise, right and left ventricular ejection fraction discordance, left ventricular end-diastolic volume index and left ventricular end-systolic volume index at rest and cardiac index at rest), four significant univariate predictors of death were identified: right ventricular ejection fraction <0.35 at rest and <0.35 at exercise, peak %Vo 2 <30% and ventricular ejection fraction discordance (Table 2 ). Peak Vo 2 was not a significant predictor of death in this patient group when analyzed as a continuous, binary (<14 or ->14 ml/kg per min) or stratified ordinal (-<10, >10 to <14, ->14 ml/kg per min) variable. In multivariate logistic regression analysis, right ventricular ejection fraction <0.35 at rest was selected as the most potent predictor of death.
From among the same candidate clinical, exercise-derived and radionuclide ventriculographic variables, three significant predictors of the combined end point were identified: right ventricular ejection fraction <0.35 at rest and <0.35 at exercise and functional class IV (Table 2) . Left ventricular enddiastolic volume index >175 ml/m 2 was a nearly significant univariate predictor of the combined end point. Neither peak Vo 2 nor peak %Vo 2 analyzed as either continuous, discrete binary or discrete stratified variables were significant predictors of the combined end point. In multivariate logistic regression analysis, right ventricular ejection fraction <0.35 at exercise was the most potent predictor of the combined end point.
An increase or decrease in either right or left ejection fraction at peak exercise was not predictive of death or the combined end point in any univariate or multivariate analysis.
Survival analysis. Univariate and multivariate predictors of overall survival are presented in Table 3 . Significant univariate predictors of overall survival included age, peak %Vo2 ->45%, right ventricular ejection fraction ->0.35 at rest and ->0.35 at exercise and functional class II. Peak Vo2 was not predictive of overall survival as either a discrete binary or stratified variable. Overall survival stratified by peak Vo 2, peak %Vo 2 and right ventricular ejection fraction at rest is displayed in Figure 2 . In a Cox proportional hazards model of overall survival, age, peak %Vo2 and right ventricular ejection fraction ->0.35 at exercise were selected as independent predictors of overall survival (Table 3) .
Univariate and multivariate predictors of event-free survival are presented in Table 3 . Significant univariate predictors of event-free survival included functional class II, right ventricular ejection fraction ->0.35 at rest and ->0.35 at exercise and peak %Vo 2 ->45%. Event-free survival stratified by peak Vo2, peak %Vo2, and right ventricular ejection fraction at rest is displayed in Figure 3 . In a Cox proportional hazards model, only right ventricular ejection fraction ->0.35 at exercise was found independently to predict event-free survival (Table 3 ).
An increase or decrease in right or left ejection fraction at peak exercise was not predictive of overall or event-free survival in any univariate or multivariate analysis.
Predictors of peak age-and gender-adjusted peak %Vo2 achieved. The relation among right and left ejection fraction at rest, peak V% and peak %go 2 is displayed in Figure 4 . Significant univariate predictors of peak %Vo 2 included percent Log-rank analysis of overall survival stratified by peak oxygen uptake (Vo2), peak age-and gender-adjusted %Vo 2 and rest right ventricular ejection fraction. Top, Overall survival stratified by peak Vo2: solid line = Vo2 -<10 ml/kg per rain; dotted line = Vo 2 10 to 14 ml/kg per min; dashed line = Vo 2 ->14 ml/kg per min. Middle, Overall survival stratified by peak %Vo2: solid line = %Vo 2 <30%; maximal heart rate achieved, right ventricular ejection fraction ->0.35 at rest and ->0.35 at exercise, ventricular ejection fraction discordance, left ventricular end-systolic volume index, functional class II and systolic blood pressure at peak exercise (Table 4) . Left ventricular ejection fraction at rest, an increase or decrease in either left or fight ejection fraction at peak exercise, left ventricular end-diastolic volume index, systolic blood pressure at rest and cardiac index at rest were not predictive of peak %Vo2. A multivariate linear regression analysis from all significant univariate candidate variables identified right ventricular ejection fraction ->0.35 at rest and percent maximal heart rate achieved as independent predictors of peak %Vo 2.
Comparison of patients by right ventricular ejection fraction. There was no difference in age, gender, diagnosis, functional class, peak V02, percent predicted heart rate achieved, left ventricular ejection fraction, left ventricular end-diastolic volume index, left ventricular end-systolic volume index, cardiac index at rest or duration of symptoms in those patients with or without preserved right ventricular ejection fraction (Table 5) . Patients with preserved right ventricular ejection fraction achieved a significantly higher peak %Vo 2 but not peak Vo 2 and had longer median overall and event-free survival. 
Discussion
The major finding of this study is the importance of right ventricular function in the prediction of both overall and event-free survival in patients with advanced heart failure. Preserved rest or exercise right ventricular ejection fraction was found to better predict both overall and event-free survival than peak Vo2. Although peak %Vo2 did predict overall and event-free survival, it was a less potent predictor than right ventricular ejection fraction. In addition, ventricular ejection fraction discordance was identified as an important predictor of functional capacity in patients with advanced heart failure.
Right ventricular ejection fraction. Many studies have shown that left ventricular ejection fraction, diastolic or systolic dimensions and filling pressures predict survival but not functional capacity in patients with advanced heart failure (32). Only a few relatively small studies have reported the prognostic significance of right ventricular ejection fraction in patients with advanced heart failure. Polak et al. (33) reported a significantly higher 2-year mortality in patients with a right ventricular ejection fraction <0.35 at rest (71% vs. 23%). Baker et al. (34) reported that radionuclide right ventricular ejection fraction at rest correlated with peak Vo2 (r = 0.7, p < 0.001) and was superior to left ventricular ejection fraction in predicting exercise capacity. By contrast, Szlachcic et al. (35) found a significant univariate but not multivariate correlation between right ventricular ejection fraction and exercise capacity. To our knowledge, the present study is the largest reported to date to show that in a homogeneous group of patients with advanced heart failure, right ventricular ejection fraction at rest or exercise predicts both survival and functional capacity as assessed by peak V% during exercise. In addition, the prognostic importance of right ventricular ejection fraction was not dependent on duration or etiology of heart failure. That the right ventricle plays an important role in determining exercise capacity in advanced heart failure is supported by previous clinical trials. Primary venodilators such as nitrates, which improve right ventricular loading conditions (in the case of nitrates by decreasing both right ventricular preload and afterload), increase exercise capacity in advanced heart failure more than primary arterial vasodilators such as enalapril, which affect right ventricular loading conditions considerably less (36, 37) . Patients treated with long-term captopril who experience a greater decrease in pulmonary vascular resistance (and reduction in right ventricular afterload) have a greater improvement in cardiac index, stroke volume index and left ventricular stroke work index than those who do not, suggesting that increased right ventricular output as a result of decreased right ventricular afterload leads to increased left ventricular filling and output in advanced heart failure (38). Observations from these studies have led to the hypothesis that exercise capacity in patients with advanced heart failure may in fact be more closely related to right ventricular than left ventricular performance (38) . Both a decrease in pulmonary vascular resistance (with concomitant decrease in right ventricular afterload) and recruitment of the contactile reserve of right ventricular free wall contribute to the normal increase in right ventricular ejection fraction seen during exercise in healthy volunteers (28, 29) . Inadequate right ventricular free wall systolic performance (from previous infarction or ischemia) or contractile reserve (from increased right ventricular afterload secondary to elevated pulmonary vascular resistance or pulmonary hypertension) both may prohibit the normal increase in right ventricular ejection fraction and right-sided cardiac output.
Peak Vo z. Peak Vo 2 has been shown in multiple studies (5, 21, 32) to predict survival in patients with symptomatic heart failure. Mancini et al. (22) classified patients with advanced heart failure referred for evaluation for cardiac transplantation into two groups on the basis of peak Vo 2. Group 1 had peak Vo: <14 ml/kg per min (n = 35, mean Vo: 11.2 + 2.5), and group 2 had peak Vo 2 >14 ml/kg per rain (n = 52, mean Vo: 19.0 _+ 4.1) during symptom-limited treadmill cardiopulmonary exercise testing. The two groups were comparable in age, functional class, left ventricular ejection fraction and cardiac index at rest; pulmonary capillary wedge pressure was significantly lower in group 2. One-year actuarial survival was reported to be significantly lower in group 1 than group 2 (70% vs. 94%, p < 0.005). This influential study serves as the basis for the current recommendation that patients with peak Vo 2 <14 ml/kg per rain be considered for transplantation (21) .
Symptom-limited upright bicycle exercise testing as used in the present study may underestimate peak Vo 2 by 5% to 10% compared with symptom-limited treadmill testing as used in the study by Mancini et al. (22) and others (21, 23) . However, April 1995 April :1143 RIGHT VENTRICULAR FUNCTION IN ADVANCED HEART FAILURE the lack of predictive power of peak Vo 2 in the present study probably results from differences in the study patients rather than the method of peak Vo 2 measurement. Although our patients did not differ from those studied by Mancini et al. (22) with regard to age, left ventricular ejection fraction or heart failure etiology, mean peak Vo2 was significantly lower in our patients (11.8 vs. 14.7 ml/kg per rain). Further, our patients appeared to be more limited in the distribution of their peak Vo2: Only five patients (7.5%) in our study achieved a Vo2 >19 ml/kg per rain, the mean value for group 2 in the study by Mancini et al. (22) . Although peak Vo 2 is of great importance in predicting overall survival in large groups of patients with impaired left ventricular ejection fraction but varying degress of functional limitation, it appears to lose its predictive value in more impaired and homogeneous patient groups. A similar loss of predictive value has been reported for left ventricular ejection fraction whenever it decreases <25% (1, 32) . In the present study, age-and gender-adjusted peak %Vo2 but not nonadjusted peak Vo 2 predicted overall and event-free survival. Peak Vo 2 and peak %Vo 2 assess not only cardiac reserve, but also the adequacy of circulatory compensatory mechanisms in heart failure (32). Such mechanisms include the level of general conditioning status, muscle mass and perfusion and vasoregulatory autonomic reflexes (39) . Given the age and gender dependence of these compensatory mechanisms, peak %Vo2 is a more sensitive indicator of functional capacity than peak Vo2, in a manner analogous to the superiority of ageadjusted rather than nonadjusted maximal heart rates during exercise. In the present study, peak %Vo 2 <30% was associated with the worst, and %Vo2 >45% was associated with the best, overall and event-free survival.
Exercise-related change in left or right ventricular ejection fraction and ventricular ejection fraction discordance. Although it has been hypothesized that the ability to augment right or left ventricular ejection fraction may predict functional capacity and prognosis in heart failure, the present study confirms previous smaller reports in demonstrating that the change in left ventricular ejection fraction or right ventricular ejection fraction from rest to peak exercise does not predict either functional capacity or prognosis. An increase or decrease in right or left ventricular ejection fraction with exercise was not associated in univariate or multivariate analysis with peak Vo2, peak %Vo2, or overall or event-free survival. Among the previous smaller studies, Szalchcic et al. (35) found no correlation with peak Vo 2 and change in left or right ventricular ejection fraction in patients with advanced heart failure. Higginbotham et al. (30) found no univariate or multivariate association between change in left ventricular ejection fraction with peak Vo2 or metabolic equivalents (METS) achieved during bicycle ergometry. As in these two previous studies, the present study also found no association between left ventricular end-diastolic volume index at rest or change in left ventricular end-diastolic volume index during exercise with peak Vo 2 or overall or event-free survival (30, 35) .
Ventricular ejection fraction discordance did not predict overall and event-free survival but did predict functional capacity. The right and left ventricles share common muscle bundles, a common interventricular septum and the pericardial space (40) (41) (42) . Acute decline in right ventricular systolic function and acute increase in right ventricular diastolic volume have been shown to impair the systolic and diastolic function of the left ventricle, respectively, as a result of ventricular interaction (43) (44) (45) . The predominant mechanism or mechanisms of ventricular interaction are not known, but constraint of ventricular diastolic filling by the presence of an intact pericardium or diastolic bowing of the interventricular septum from preferential right or left ventricular diastolic filling probably play an important role (46) . Preserved right ventricular systolic function and resultant smaller right ventricular end-diastolic volume may minimize the adverse effects of right ventricular interaction on left ventricular systolic performance in advanced heart failure and result in improved functional capacity. If validated in larger studies, ventricular ejection discordance, a noninvasive, easily acquired measure of functional capacity, may be of potential use in the initial stratification of patients with advanced heart failure.
Contrary to studies of patients with varying degrees of heart failure and functional limitation, the present study of a homogeneous patient group with advanced heart failure and marked functional limitation found that left ventricular volumetric indexes such as left ventricular end-diastolic volume index and left ventricular end-systolic volume index did not predict functional capacity or overall or event-free survival.
Determinants of age-and gender-adjusted predicted peak %Voz achieved. Analysis of the univariate and multivariate determinants of peak %Vo 2 corroborated the important functional role of the right ventricle in advanced heart failure. In multivariate analysis, right ventricular ejection fraction ->0. 35 at exercise emerged as the most important predictor of peak %Vo 2. In multivariate models, including a smaller patient group with complete catheterization and first-pass rest and exercise radionuclide ventriculography data, ventricular discordance and right ventricular stroke work index entered the model in place of right ventricular ejection fraction ->0.35 at exercise as the most important predictors of peak %Vo2. Thus, right ventricular function, measured by either right ventricular ejection fraction, right and left ventricular ejection fraction discordance or right ventricular stroke work index, is an important determinant of peak %Vo 2 in these patients.
Study limitations. The present study included a relatively small number of patients. Medical therapy had been only recently maximized in these patients, many of whom were previously suboptimally treated. Exercise testing and peak Vo2 determinations were not performed serially in these patients. Symptom-limited bicycle ergometric exercise testing was used, which may underestimate peak Vo 2 by 5% to 10% compared with symptomqimited treadmill exercise. In the present study, right heart cardiac catheterization within 3 weeks of exercise testing was performed in only 66% of patients after optimization of digoxin, diuretic drugs and angiotensin-converting enzyme inhibitors; because not all patients underwent catheterization, hemodynamic variables were not included in this analysis. Further, the results of this study of patients with advanced heart failure may not be readily generalizable or applicable in predicting outcome or Vo2 in patients with a milder degree of heart failure.
Summary. The present study identified rest and exercise right ventricular ejection fractions as important predictors of overall and event-free survival in patients with advanced heart failure. Preservation of right ventricular ejection fraction was the single most important predictor of overall and event-free survival in this referral group of patients. Peak %Vo 2 but not peak Vo 2 was predictive of overall and event-free survival in this study; this observation probably reflected the more homogeneous patient group in this study compared with those in previous studies. The present study also identified rest or exercise ventricular ejection fraction and ventricular ejection fraction discordance as important predictors of functional capacity in advanced heart failure. Larger studies using firstpass radionuclide ventriculography in both advanced and milder degrees of heart failure are necessary to determine the prognostic value of right ventricular function and ventricular ejection fraction discordance in such patients.
